Sphingolipid metabolites such as ceramides and sphingoid bases are important modulators of cell survival, cell proliferation, angiogenesis, migration and vascular integrity. Our in vitro and in vivo data indicate that sphingosine 1-phosphate (SIP), a naturally occurring bioactive lipid, is an essential angiogenic factor that regulates vascular endothelial cell (EC) barrier permeability, a crifical and defining feature of ALL SIP acts extracellularly through its G-protein coupled S1P1-5 receptors and there is evidence that supports an intracellular role of SIP in calcium release and cell proliferation.SIP mediated cellular responses are regulated by its synthesis, catalyzed by sphingosine kinases (SphKs), and degradation mediated by SIP phosphatases, and SI P lyase (SI PL). In the course of our studies, we observed that alteration of SphKs and SI PL expression in animals or human lung microvascular endothelial cells (jHLMVECs) modulated LPSnduced inflammatory responses and barrier function suggesting a key role for these enzymes in maintenance of barrier function and integrity. Project 1 will test the hypothesis that """"""""Modulation of intracellular S1P by SphKs and S1 PL of the endothelium regulates LPS-induced lung inflammation and barrier dysfunction"""""""". SA#1 will define molecular mechanisms of SphKI and 2 and SI PL regulation of LPSinduced inflammatory responses in animal and HLMVEC culture models.. We will utilize a combination of molecular, biochemical and lipidomics approach to evaluate and quantify intracellular SIP accumulation and determine its role in modulation IL-6 release and barrier dysfunction in the endothelium. SA#2 will characterize ALI associated single nucleotide polymorphisms (SNPs) in SphKs and SI PL and conduct SNPspecific association studies. SA#3 will determine the effectiveness of SphK activator(s) and S1PL inhibitor(s) as potential therapeutic agents in murine model of LPS-induced lung injury. Together, this Project will greatly advance studies proposed in other Projects, clarify the key roles of SphKs and SI PL in ALI pathobiology and facilitate the development of novel therapeutic agents of sphingolipid metabolism in ameliorating sepsisinduced inflammation and lung injury.

Public Health Relevance

Acute and sub-acute inflammatory lung injuries are common but devastating disorders resulting from insults such as sepsis, and radiation therapy for thoracic malignancies with a mortality rate of 30-50%! Specific. therapies currently do not exist for the treatment of ALI. The propsed studies will define key sphingolipid metabolizing enzymes as novel targets of therapy against sepsis-induced lung injury.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL098050-03
Application #
8502317
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
Project End
Budget Start
2013-06-01
Budget End
2014-05-31
Support Year
3
Fiscal Year
2013
Total Cost
$336,295
Indirect Cost
$122,095
Name
University of Illinois at Chicago
Department
Type
DUNS #
098987217
City
Chicago
State
IL
Country
United States
Zip Code
60612
Ackerman, Steven J; Park, Gye Young; Christman, John W et al. (2016) Polyunsaturated lysophosphatidic acid as a potential asthma biomarker. Biomark Med 10:123-35
Camp, Sara M; Chiang, Eddie T; Sun, Chaode et al. (2016) ""Pulmonary Endothelial Cell Barrier Enhancement by Novel FTY720 Analogs: Methoxy-FTY720, Fluoro-FTY720, and β-Glucuronide-FTY720"". Chem Phys Lipids 194:85-93
Ebenezer, David L; Fu, Panfeng; Natarajan, Viswanathan (2016) Targeting sphingosine-1-phosphate signaling in lung diseases. Pharmacol Ther 168:143-157
Viswanathan, P; Ephstein, Y; Garcia, J G N et al. (2016) Differential elastic responses to barrier-altering agonists in two types of human lung endothelium. Biochem Biophys Res Commun 478:599-605
Black, Katharine E; Berdyshev, Evgeny; Bain, Gretchen et al. (2016) Autotaxin activity increases locally following lung injury, but is not required for pulmonary lysophosphatidic acid production or fibrosis. FASEB J 30:2435-50
Ebenezer, David L; Fu, Panfeng; Suryadevara, Vidyani et al. (2016) Epigenetic regulation of pro-inflammatory cytokine secretion by sphingosine 1-phosphate (S1P) in acute lung injury: Role of S1P lyase. Adv Biol Regul :
Jiang, Ying; Sverdlov, Maria S; Toth, Peter T et al. (2016) Phosphatidic Acid Produced by RalA-activated PLD2 Stimulates Caveolae-mediated Endocytosis and Trafficking in Endothelial Cells. J Biol Chem 291:20729-38
Zhang, Chongben; Hwarng, Gwen; Cooper, Daniel E et al. (2015) Inhibited insulin signaling in mouse hepatocytes is associated with increased phosphatidic acid but not diacylglycerol. J Biol Chem 290:3519-28
Huang, Long Shuang; Berdyshev, Evgeny V; Tran, John T et al. (2015) Sphingosine-1-phosphate lyase is an endogenous suppressor of pulmonary fibrosis: role of S1P signalling and autophagy. Thorax 70:1138-48
Letsiou, Eleftheria; Sammani, Saad; Zhang, Wei et al. (2015) Pathologic mechanical stress and endotoxin exposure increases lung endothelial microparticle shedding. Am J Respir Cell Mol Biol 52:193-204

Showing the most recent 10 out of 48 publications